Daniel E. Bergsagel
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Hematology 52
- Multiple Myeloma Research and Treatments 34
- Chronic Myeloid Leukemia Treatments 9
- Acute Myeloid Leukemia Research 5
- Oncology 27
- Peptidase Inhibition and Analysis 15
- Co-authors
- E. A. McCulloch (7 shared papers)R. Hasselback (5 shared papers)G. R. Langley (1 shared paper)Anthony B. Miller (1 shared paper)A Bailey (1 shared paper)R. Neil MacDonald (1 shared paper)Andrew R. Belch (5 shared papers)Makio Ogawa (4 shared papers)
- Journals
- Blood (7 papers)British Journal of Haematology (6 papers)Science (4 papers)Investigational New Drugs (2 papers)Annual Review of Medicine (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Daniel E. Bergsagel
75 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 109
- Hematology 1.6k
- Oncology 1.2k
- Genetics 401
- Molecular Biology 1.1k
- Pathology and Forensic Medicine 216
Countries citing papers authored by Daniel E. Bergsagel
This map shows the geographic impact of Daniel E. Bergsagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Bergsagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Bergsagel more than expected).
Fields of papers citing papers by Daniel E. Bergsagel
This network shows the impact of papers produced by Daniel E. Bergsagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Bergsagel. The network helps show where Daniel E. Bergsagel may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Bergsagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mouse myeloma tumor stem cells: a primary cell culture assay. | 1971 | 326 |
| 2 | 1979 | 315 | |
| 3 | 1991 | 152 | |
| 4 | 1988 | 128 | |
| 5 | 1968 | 118 | |
| 6 | 1972 | 102 | |
| 7 | Myeloma : biology and management | 1995 | 84 |
| 8 | Growth characteristics of a mouse plasma cell tumor. | 1968 | 81 |
| 9 | 1973 | 79 | |
| 10 | 1995 | 79 | |
| 11 | Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide. | 1972 | 69 |
| 12 | 1956 | 68 | |
| 13 | Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses. | 1968 | 55 |
| 14 | 1967 | 52 | |
| 15 | 1965 | 44 | |
| 16 | 1975 | 44 | |
| 17 | 1989 | 43 | |
| 18 | 1981 | 43 | |
| 19 | The chronic leukemias: a review of disease manifestations and the aims of therapy. | 1967 | 43 |
| 20 | The incidence and epidemiology of plasma cell neoplasms. | 1995 | 42 |
About Daniel E. Bergsagel
Daniel E. Bergsagel is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 77 papers that have together received 2.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (34 papers), Peptidase Inhibition and Analysis (15 papers), Protein Degradation and Inhibitors (11 papers), Chronic Myeloid Leukemia Treatments (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Hematology (1.6k citations), Oncology (1.2k citations), Genetics (401 citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (216 citations). Daniel E. Bergsagel has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include E. A. McCulloch, R. Hasselback, G. R. Langley, Anthony B. Miller, A Bailey, R. Neil MacDonald, Andrew R. Belch, Makio Ogawa, Philip J. Migliore and Fred Valeriote. Their work appears in journals such as Blood, British Journal of Haematology, Science, Investigational New Drugs and Annual Review of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.